Stay updated on Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedA notice appears at the top of the page about NIH’s website transition, including a statement that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check35 days agoChange DetectedThe study record history shows a new revision label (v3.7.0) replacing the previous v3.6.6. This indicates a platform-level revision of the history interface rather than a content update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history shows a platform revision updated to v3.6.6, replacing the previous v3.6.5. This change represents a minor system update rather than modifications to study data or page content.SummaryDifference0.1%

- Check77 days agoChange DetectedThe history now reflects a platform update from v3.6.4 to v3.6.5. This is a routine software upgrade with no changes to the study data or record details.SummaryDifference0.1%

Stay in the know with updates to Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.